Tag Archives: Ali Mahdavi

Emblem Corp

Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation

Emblem Announces Exclusive Agreement with Canntab Therapeutics for Cannabinoid Based Oral Sustained Release Formulation

PARIS, Ontario, Oct. 3, 2017 /Weed Wire/ — Emblem Corp. (TSXV:EMC) (EMC.WT) (“Emblem” or the “Company”) announced today that it has entered into a Collaboration and Licensing Agreement (the “Agreement”) with Canntab Therapeutics Limited (“Canntab”) of Toronto.

Canopy Growth

Canopy Growth and Mettrum Announce Respective Shareholder Approvals of the Plan of Arrangement

SMITH FALLS, Ontario, Jan. 27, 2017 /Weed Wire/ — Canopy Growth Corporation (“Canopy Growth”) (TSX:CGC) and Mettrum Health Corp. (“Mettrum”) (TSX VENTURE:MT) (together, the “Companies”) are pleased to announce the successful results of the Special Meetings of Shareholders of Canopy Growth and Mettrum, held in Smiths Falls, Ontario and Toronto, Ontario, respectively, to approve Canopy Growth’s acquisition of Mettrum by way of a plan of arrangement (the “Arrangement”), as previously announced by the Companies on December 1, 2016.

Tweed JA

Canopy Growth Enters Into Agreement to Acquire Mettrum

SMITH FALLS, Ontario, Dec. 1, 2016 /Weed Wire/ — Canopy Growth Corporation (TSX: CGC) (“Canopy Growth” or the “Company”) and Mettrum Health Corp. (“Mettrum”) (TSXV: MT) are pleased to announce that they have entered into a definitive arrangement agreement.

Mettrum

Mettrum to Sell Non-Core Subsidiary for $7 Million and Enters Three Year Product Supply Agreement

TORONTO, Ontario, Sept. 20, 2016 /Weed Wire/ — Mettrum Health Corp. (“Mettrum” or the “Company”) (TSX VENTURE:MT) is pleased to announce that it has entered into an agreement with Cannabis Care Canada Inc. (“CCC”) to sell to CCC its wholly-owned subsidiary Mettrum (Bennett North) Ltd. Mettrum Health Corp. announced that it has entered into an agreement with Cannabis Care Canada Inc. to sell to CCC its wholly-owned subsidiary Mettrum (Bennett North) Ltd.

Mettrum

Mettrum Health Corp. Closes $15 Million Bought Deal Offering of Common Shares

TORONTO, Ontario, Aug. 26, 2016 /Weed Wire/ — Mettrum Health Corp. (“Mettrum” or the “Company”), (TSX VENTURE:MT), a vertically integrated provider of cannabis products, is pleased to announce that it has completed its previously announced bought deal offering of 5,661,000 common shares of the Company (the “Shares”), at a price of $2.65 per Share for aggregate gross proceeds of $15,001,650 (the “Offering”).

Mettrum

Mettrum Receives License Amendment for the Sale of Medical Cannabis and Extracts at its 60,000 Square Foot Facility in Bowmanville

TORONTO, Ontario, May 9, 2016 /Weed Wire/ — Mettrum Health Corp. announced that the Company has received an amendment to its license to include both the production and sale of medical cannabis and extracts from Health Canada under the Marihuana for Medical Purposes Regulations (Canada)(“MMPR”) at its 60,000 square foot production and distribution facility located in Bowmanville, Ontario.


Top